EPCORITAMAB
Epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial
EPCORITAMAB (14826H)
14826H
Manner of administration:Injection
Restriction
Indication: Relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
Treatment phase: Transitioning from non-PBS to PBS-subsidised treatment - Grandfather arrangements
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 9 | DPMQ: $9,230.77 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||